Evidence map›Paper›PMID 37615186›Full record

ArticleInternational journal of molecular medicine2023

[Retracted] KIF22 promotes bladder cancer progression by activating the expression of CDCA3.

Kai Li, Song Li, Shuai Tang, Minghao Zhang, Zhen Ma, Qi Wang, Fangmin Chen

RetractedOpen access · hybridAbstract readRetraction Notice
In one paragraph

Article in International journal of molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kai LiDepartment of Urology, Tianjin Third Central Hospital Affiliated to Nankai University, Tianjin 300170, P.R. China.
Song LiDepartment of Urology, Tianjin Third Central Hospital Affiliated to Nankai University, Tianjin 300170, P.R. China.
Shuai TangDepartment of Urology, Tianjin Third Central Hospital Affiliated to Nankai University, Tianjin 300170, P.R. China.
Minghao ZhangDepartment of Urology, Tianjin Third Central Hospital Affiliated to Nankai University, Tianjin 300170, P.R. China.
Zhen MaDepartment of Urology, Tianjin Third Central Hospital Affiliated to Nankai University, Tianjin 300170, P.R. China.
Qi WangDepartment of Urology, Tianjin Third Central Hospital Affiliated to Nankai University, Tianjin 300170, P.R. China.
Fangmin ChenDepartment of Urology, Tianjin Third Central Hospital Affiliated to Nankai University, Tianjin 300170, P.R. China.
Nankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that certain of the colony formation assay data shown in Fig. 3A on p. 7 and the immunohistochemistry data in Fig. 5D were strikingly similar to data that had already appeared in previous publications. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were under consideration for publication, prior to its submission to

Indexed as

bladder cancercell division cycle‑associated protein 3kinesin family member 22proliferationtherapeutic target

Identifiers

PMID37615186
PMCPMC10495753
OpenAlexW4386028527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.